The following is a summary of “Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population,” published in the December 2022 issue of Primary care by Kumar, et al.
The cause of non-alcoholic fatty liver disease (NAFLD), a severe risk factor for liver cirrhosis due to the additional fat buildup in the liver, remained unknown. For a study, researchers evaluated the glycaemic state and NAFLD in healthy adults who were receiving routine medical examinations.
The descriptive research examined 192 healthy people between the ages of 30-70 who had undergone general health examinations. The history, clinical examination, hematological and radiographic workup, as well as statistical analysis of the data, were completed.
The research sample size was 190, and the study population’s age ranged from 30 to 70 years with an average age of 50. In our research group, the prevalence of prediabetes was 35.93%, diabetes was 17.18%, and euglycemia was 45.83%. 30% and 31%, respectively, of diabetics and prediabetics, had elevated transaminases. Around 19% of those with euglycemia had elevated transaminase. On ultrasound scans, fatty liver was more common in the diabetes group (57.6%) than in the prediabetic group (46.4%). Around 22.7% of the people with normal blood sugar levels had fatty liver.
If left untreated, NAFLD, which has several causes and is linked to diabetes, can proceed to liver cirrhosis. At the primary care level, there was a need to place more emphasis on screening, education, dietary counseling, and treatment.